Drugs / SYN008
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04944602 | Jul 2021 → Mar 2023 | chronic urticaria | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SYN008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04944602 ↗ |
| Route | Subcutaneous | “SYN008 300 mg s.c.” NCT04944602 ↗ |